Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies?

[1]  K. Jellinger,et al.  Critical evaluation of the Braak staging scheme for Parkinson's disease , 2010, Annals of neurology.

[2]  H. Shill,et al.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.

[3]  D. Dickson,et al.  Incidental Lewy body disease and preclinical Parkinson disease. , 2008, Archives of neurology.

[4]  K. Jellinger,et al.  The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease , 2008, Neuropathology and applied neurobiology.

[5]  C. Adler,et al.  Evaluation of α-synuclein immunohistochemical methods used by invited experts , 2008, Acta Neuropathologica.

[6]  R. Petersen,et al.  Validation of the Neuropathologic Criteria of the Third Consortium for Dementia With Lewy Bodies for Prospectively Diagnosed Cases , 2008, Journal of neuropathology and experimental neurology.

[7]  K. Jellinger.  A critical reappraisal of current staging of Lewy-related pathology in human brain , 2008, Acta Neuropathologica.

[8]  M. Graeber,et al.  The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging , 2008, Neuropathology and applied neurobiology.

[9]  C. Adler,et al.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease , 2008, Acta Neuropathologica.

[10]  I. McKeith,et al.  Patterns and stages of α-synucleinopathy , 2008, Neurology.

[11]  I. Alafuzoff,et al.  Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance , 2008, Acta Neuropathologica.

[12]  G. Halliday,et al.  The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.

[13]  T. Montine,et al.  RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy‐Related Pathology in the Dementia Patient , 2008, Brain pathology.

[14]  H. Braak,et al.  Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.

[15]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[16]  D J Brooks,et al.  DLB and PDD boundary issues , 2007, Neurology.

[17]  H. Braak,et al.  Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons , 2007, Acta Neuropathologica.

[18]  Michael L. Kramer,et al.  Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.

[19]  Dennis W. Dickson,et al.  Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.

[20]  A. Probst,et al.  α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects , 2006, Neuropathology and applied neurobiology.

[21]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[22]  B. Boeve,et al.  α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals , 2006, Neurology.

[23]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[24]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[25]  D. Aarsland,et al.  Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study , 2005, Annals of neurology.

[26]  D. Dickson,et al.  Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? , 2005, Parkinsonism & related disorders.

[27]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[28]  Dag Aarsland,et al.  Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity? , 2004, Journal of geriatric psychiatry and neurology.

[29]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[30]  K. Jellinger,et al.  α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study , 2003, Acta Neuropathologica.

[31]  T. Iwatsubo,et al.  Accumulation of Phosphorylated α‐Synuclein in Aging Human Brain , 2003 .

[32]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[33]  R. Terry.  Cell death or synaptic loss in Alzheimer disease. , 2000, Journal of neuropathology and experimental neurology.

[34]  R. Hamilton,et al.  Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.

[35]  M. Farrer,et al.  Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p , 2000, Acta Neuropathologica.

[36]  G. Glosser,et al.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.

[37]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[38]  E. Tangalos,et al.  An anatomy of the autopsy, Olmsted County, 1935 through 1985. , 1989, Mayo Clinic proceedings.

[39]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[40]  J. Ludwig,et al.  Assessing the autopsy. , 1987, The American journal of pathology.

[41]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[42]  Michael L. Kramer,et al.  Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  P. Box.  α-synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005 .

[44]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[45]  Hideo Fujiwara,et al.  Accumulation of phosphorylated alpha-synuclein in aging human brain. , 2003, Journal of neuropathology and experimental neurology.

[46]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[47]  Daniel J Schaid,et al.  Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.